amide promotes cell migration and proliferation through activation of ERK1/2 in human aortic smooth muscle cells.
down major extracellular barriers such as basal membranes, interstitial collagens, and proteoglycans (33) , thereby playing an essential role in the regulation of VSMC migration and proliferation. Reactive oxygen species (ROS), generated by a variety of extracellular and intracellular mechanisms, have gained attention as novel signal mediators that regulate signal transduction events, including mitogen-activated protein kinases (MAPKs) (26) . ROS integrate cellular signaling pathways for VSMC proliferation and migration (20) .
Lactosylceramide (LacCer) is a bioactive sphingolipid, a class of lipids derived from the aliphatic amino alcohol sphingosine. The synthesis of LacCer is started by the sequential transfer of glucose and galactose moieties from UDP-glucose and UDP-galactose to ceramide, which is composed of erythrosphingosine and fatty acid with C 12ϳ16 carbon atoms in the acyl chain. LacCer is synthesized from ceramide generated by the de novo pathway and from ceramide generated from other sphingolipids via the hydrolysis of sphingomyelin by the action of sphingomyelinases (6, 34) . Physiological concentrations of plasma LacCer have been reported from 4.7 to 10.29 M (13, 32) . LacCer presents in vascular cells such as endothelial cells, SMCs, macrophages, neutrophils, platelets, and monocytes (6, 10) . An increased level of LacCer has been reported in the plasma of patients with familial hypercholesterolemia and in human atherosclerotic plaques (11, 12, 25) . In vitro studies have suggested that LacCer plays a significant role in atherosclerogenesis by stimulating neutrophil adhesion to endothelial cells and VSMC proliferation (5, 9, 16) . However, the molecular events of LacCer-induced VSMC proliferation are largely unknown. To our best knowledge, there is no report on the biological effect of LacCer on VSMC migration.
In the present study, we investigated the direct effect of LacCer on human aortic SMC (AoSMC) migration and proliferation. We further examined the underlying molecular mechanism of the effects of LacCer, including oxidative stress, MAPK activation, and gene expression, in AoSMCs. This study provides experimental evidence that LacCer induces VSMC migration and proliferation and may contribute to the pathogenesis of atherosclerosis and restenosis.
MATERIALS AND METHODS
Chemicals and reagents. LacCer (bovine) was purchased from EMD Chemicals (San Diego, CA). Anti-human ␤-actin antibody and seleno-L-methionine (SeMet) were obtained from Sigma Aldrich (St. Louis, MO). Anti-human ␤ 3-integrin (CD61) and ␣v-integrin antibodies were purchased from BD Biosciences Pharmingen (San Diego, CA). Human PDGF-BB, anti-human PDGFR-B antibody, and antihuman MMP1 and MMP2 antibodies were obtained from R&D Systems (Minneapolis, MN). Dihydroethidium (DHE) was obtained from Molecular Probes (Eugene, OR). Mouse anti-LacCer IgM Huly-m13 was purchased from Ancell (Bayport, MN). Anti-␣v␤3-integrin neutralizing antibody was obtained from Millipore (Billerica, MA). Inhibitors of ERK1/2 (PD-98059) and calcein AM were purchased from Calbiochem (San Diego, CA). Mn (III) tetrakis (4-benzoic acid)porphyrin (MnTBAP) was purchased from A.G. Scientific (San Diego, CA).
Cell cultures. AoSMCs were purchased from Lonza (Walkersville, MD) and routinely cultured in smooth muscle medium-2 (SmGM-2) with growth factors and antibiotics (SmGM-2 Bullet Kit) supplemented with 10% FCS. Before each experiment, AoSMCs were placed in the basal medium (SmGM-2 medium with 1% FCS) without the addition of growth factors for 16 h (serum starvation). AoSMCs were used between passages 3 and 7. To observe the effect of LacCer on AoSMC migration and proliferation, serum-starved cells were treated with different concentrations of LacCer (0.5-20 M) with 0.1% DMSO as a negative control and 5% FCS as a positive control.
Cell migration assay. Cell migration was measured using a modified Boyden chamber assay including fluoroblock transwell migration plates (Becton Dickinson Labware, Franklin Lakes, NJ). Briefly, serum-starved cells were seeded in the upper chamber (250 L, 1 ϫ 10 5 cells/well in a 24-well plate). Then, 750 l of the basal medium with different concentrations of LacCer were added to the lower chamber. After 6 -24 h of incubation, cells were labeled with 50 nM calcein AM, a fluorescence dye that labels living cells. The fluorescence of the cells that migrated to the lower chamber was measured from the bottom using a fluorescence microplate reader at 485/535-nm wavelength. Migrated cells in the filters were also observed under a fluorescence microscope (Olympus, Tokyo, Japan).
Wound healing assay. AoSMCs were grown to 90% confluence in a six-well plate, and a scratch was made with a sterile cell scraper. The starting point was marked with a marker pen at the bottom of the plate. Cells were washed with basal medium twice and were incubated with DMSO (0.1%) or LacCer (10 M) or 5% FCS in the basal medium. Cells were incubated for 16 h and stained with calcein AM (23) . Photos were taken using the fluorescence microscope.
Cell proliferation. AoSMC proliferation was also measured with a CellTiter 96 AQueous One Solution Cell Proliferation Assay (MTS) kit (Promega), as described in our previous study (23) . Briefly, AoSMCs (2,000 cells/well in a 96-well plate) were treated with various concentrations of LacCer for 24, 48, and 72 h after overnight starvation. Cells were then incubated with 20 l of MTS reagent in 100 l of fresh culture medium for 2 h at 37°C in a humidified and 5% CO2 atmosphere. The absorbance at 490 nm was recorded using an ELISA plate reader (EL800, Bio-Tek Instruments). A growth curve with the absorbance of the MTS assay was directly correlated with the number of metabolically active living cells. The percentage of the absorbance was calculated against untreated cells.
RNA isolation and real-time RT-PCR. Serum-starved AoSMCs were treated with LacCer (10 M) or DMSO (0.1%) for 24 h, and total RNA was isolated for real-time PCR analysis, as described in our previous study (24) . Human PDGFR-B, MMPs, and integrins as well as ␤-actin primers were designed using Beacon Designer software. Sample cycle threshold (C t) values were determined from plots of relative fluorescence units (RFU) versus the PCR cycle number during exponential amplification so that sample measurement comparisons were possible. The mRNA levels of these molecules in each sample were calculated as 2 Western blot analysis. AoSMCs were treated with LacCer (10 M) or DMSO (0.1%) for 24 h, and proteins were extracted with cell lysis buffer (Cell Signaling Technology, Danvers, MA). Equal amounts of total proteins (50 g) were separated by 10% SDS-PAGE and then transblotted onto a Hybond-P polyvinylidene difluoride membrane. The membrane was incubated with the primary antibody at 4°C overnight. Dilutions were 1:500 for human ␣ v-integrin and ␤3-integrin, 1:200 for MMP1 and MMP2, and 1:500 for PDGFR-B. The membrane was then incubated in the horseradish peroxidase-linked secondary antibody for 50 min. Bands were visualized with ECL Plus chemiluminescent substrate (Amersham Biosciences). Densitometric measurement was performed to quantify the relative expression of target proteins versus ␤-actin (AlphaEaseFC software, Alpha Innotech, San Leandro, CA).
DHE staining detected by flow cytometry. Superoxide anion production was determined by DHE staining. DHE is freely permeable to cells. In the presence of superoxide anion, DHE is oxidized to ethidium bromide with red fluorescence and is trapped by intercalating with DNA. Ethidium bromide is excited at 488 nm with an emission spectrum of 610 nm. Thus, the amount of ethidium bromide detected by fluorescence measurement is well correlated with the level of cellular superoxide anion. Cultured cells were treated with LacCer (10 M) or DMSO (0.1%) for 60 min. The treatment was halted by washing cells three times with PBS. One milliliter of DHE (3 M) in PBS was added into each well of the six-well plate and incubated for 20 min at room temperature. The staining was then analyzed by FACS Calibur (Becton Dickinson, San Jose, CA).
MAPK activation. The MAPK phosphorylation state of AoSMC lysates was analyzed by Bio-Plex phosphoprotein and total target assays (Bio-Rad, Hercules, CA) as described in our previous publications (23, 24) . Briefly, serum-starved AoSMCs were treated with LacCer (10 M), and cell lysates were collected at different time points of 0, 5, 7, 10, 15, 20, 30, 45, and 60 min. Phosphoprotein and total proteins of MAPKs were analyzed by a Luminex 100TM analyzer (Bio-Rad). Data are presented as fold changes of phosphorylated to total MAPK proteins in each sample. In a separate experiment, serum-starved AoSMCs were treated with LacCer and/or antioxidants (MnTBAP and SeMet) for 0 -30 min. ERK1/2 phosphorylation was detected by typical Western blot analysis.
Statistical analysis. Data are presented as means Ϯ SE. Statistical significance was determined by a Student's t-test (two tailed). Values of P Ͻ 0.05 were considered significant.
RESULTS
LacCer promotes AoSMC migration. Since VSMC migration and proliferation are critical steps in atherosclerosis and restenosis, we determined whether LacCer could affect AoSMC migration. Cells were treated with increasing concentrations of LacCer (1-20 M) in the lower chamber with 0.1% DMSO as a negative control in a modified Boyden chamber assay. Cells that migrated through a polystyrene membrane with 8-m size pores were stained with calcein AM, a fluorescent dye, and measured with a fluorescence reader. As shown in Fig. 1A , LacCer significantly increased AoSMC migration in a concentration-dependent manner with the maximal effect at 10 M (up to 192% compared with the negative control, P Ͻ 0.01). The increased AoSMC migration was visualized under a fluorescent microscope (Fig. 1B) . To confirm these findings, we performed a time-course experiment (6, 12, 18 , and 24 h) and observed a significant effect of LacCer on cell migration as early as 6 h after cells were seeded, and the most significant effect was observed at 24 h (Fig. 1C) . To further confirm the effect of LacCer on AoSMC migration, we performed a wound healing assay. LacCer (10 M) promoted the cell wound healing process compared with the negative control after 16 h of treatment (Fig. 1D ). In addition, we performed separate experiments on AoSMC migration with FCS and LacCer. LacCer significantly increased AoSMC migration in the presence with FCS (1% and 3%) compared with the FCS alone treatment groups ( Fig. 2A) . Thus, LacCer has additive effects with FCS on AoSMC migration. Furthermore,
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we confirmed the specific effect of LacCer using LacCer neutralizing antibody, which effectively blocked LacCer-induced AoSMC migration (Fig. 2B) .
LacCer increases AoSMC proliferation. To evaluate the direct effect of LacCer on AoSMC proliferation, we performed a nonradioactive colorimetric (MTS) assay. Serum-starved AoSMCs were treated for 24 h with increasing concentrations (0.5-10 M) of LacCer. As shown in Fig. 3A , 0.1% DMSO (negative control) did not change cell proliferation compared with cells in the basal medium alone. LacCer significantly increased AoSMC proliferation in a concentration-dependent manner, with the maximum effect up to 159.6% compared with the negative control at the concentration of 10 M, whereas 5% FCS (positive control) increased cell proliferation up to 212% (P Ͻ 0.01, n ϭ 8). In addition, time-course experiments confirmed the effect of LacCer on AoSMC proliferation ( Fig.  3B ; from up to 160% to 188% at 24 to 72 h, respectively, compared with the negative control, P Ͻ 0.01, n ϭ 6).
LacCer increases the expression of PDGFR-B,
, and MMP2 in AoSMCs. Functions of PDGF-B are mediated through its receptor, PDGFR-B, which is a major regulator of VSMC migration and proliferation. Integrins and MMPs play an essential permissive role in cell migration. The mRNA levels of PDGFR-B, MMPs, and integrins in AoSMCs by LacCer treatment were first evaluated by real-time PCR. As shown in Fig. 4A , LacCer significantly increased the mRNA levels of PDGFR-B, ␤ 3 -integrin, ␣ vintegrin, MMP1, and MMP2 (but not ␤ 5 -integrin and ␣ 3 -integrin) in a concentration-dependent manner with the maximal effect at 10 M up to 222%, 214%, 200%, 174%, and 182%, respectively, compared with DMSO-treated controls (P Ͻ 0.05, n ϭ 4). In addition, protein levels of these molecules were determined by Western blot analysis. As shown in Fig. 4B , LacCer (10 M) increased the protein levels of PDGFR-B, ␤ 3 -integrin, ␣ v -integrin, MMP1, and MMP2 in AoSMCs. Further quantitation demonstrated that LacCer significantly increased the protein levels of PDGFR-B, ␣ v -integrin, ␤ 3 -integrin, MMP1, and MMP2 up to 192%, 243%, 278%, 206%, and 243%, respectively, compared with DMSOtreated control cells (P Ͻ 0.01, n ϭ 3; Fig. 4C ). Thus, LacCer upregulates several key molecules related to SMC migration and proliferation in AoSMCs. In addition, we performed a separate experiment of human AoSMC migration with LacCer treatment with or without the ␣ v ␤ 3 -integrin neutralizing antibody, which significantly blocked LacCer-induced AoSMC migration by 40% compared with the LacCer alone-treated group (P Ͻ 0.01; Fig. 4D ). These data indicate that ␣ v ␤ 3 -integrin may be functionally involved in LacCer-induced AoSMC migration.
Superoxide anion production is involved in LacCer-induced cell migration and proliferation in AoSMCs. To explore whether oxidative stress could be involved in the molecular mechanism of LacCer-induced AoSMC proliferation and migration, we examined the effects of LacCer on superoxide anion generation and antioxidant applications. Superoxide anion levels were determined by fluorescence staining with DHE, a compound chemically oxidized to the fluorescent DNAintercalating agent ethidium in proportion to the amount of superoxide present (7) . The fluorescence for superoxide anion was analyzed by flow cytometry analysis. As shown in Fig. 5,  A and B, LacCer (10 M) significantly increased superoxide anion production up to 24.6% of the cell population compared with the DMSO-treated negative control (4.69%, P Ͻ 0.01, n ϭ 3) after 60 min of treatment. To confirm the functional role of the LacCer-induced increase in superoxide anion production, antioxidants were used in the AoSMC cultures for cell migration and proliferation. Indeed, the antioxidant MnTBAP (3 M), a SOD mimetic, completely blocked LacCer-induced AoSMC migration and proliferation (P Ͻ 0.01, n ϭ 6; Fig. 5 , C and 5D). MnTBAP alone had no effect on cell proliferation and migration. A second antioxidant, SeMet (20 M), also effectively blocked the LacCer-induced increase in AoSMC migration and proliferation (P Ͻ 0.01, n ϭ 4; Fig. 6, C and D) . Thus, oxidative stress plays an important role in LacCerinduced AoSMC migration and proliferation.
Activation of ERK1/2 is involved in LacCer-induced cell migration and proliferation in AoSMCs.
To better understand the signal pathways involved in LacCer-induced AoSMC migration and proliferation, we investigated the possible involvement of MAPKs, including ERK1/2, p38 kinase, and JNK, because the activation of MAPKs is highly redox sensitive. Serum-starved AoSMCs were incubated with LacCer (10 M), and cell lysates were collected at different time points. A Bio-Plex System (Bio-Rad) was used to detect phosphorylated and total proteins of p38, ERK2, and JNK. The ratio of phosphorylated and total protein at each time point was used to evaluate the activation of ERK2, p38, and JNK. As shown in Fig. 6A , ERK2 phosphorylation increased from 5 min, reached its peak up to 6-fold at 10 min, and recovered after 30 min after LacCer treatment. However, no significant changes were observed for JNK and p38. These results suggest that LacCer may activate the ERK2 signaling pathway in AoSMCs but not JNK and p38. In a separated experiment, AoSMCs were treated with LacCer and/or antioxidants (MnTBAP and SeMet) for 0 -30 min. ERK1/2 phosphorylation was detected by Western blot analysis and showed consistent results with the Bio-Plex data. LacCer substantially increased ERK1/2 phosphorylation at 10 min, whereas MnTBAP and SeMet effectively inhibited LacCerinduced ERK1/2 phosphorylation (Fig. 6B) .
To determine the functional impact of ERK1/2 activation in AoSMCs, we used a specific ERK inhibitor in LacCer-induced AoSMC migration and proliferation. AoSMCs were incubated with the ERK1/2 inhibitor PD-98059 (10 M) for 1 h before and during LacCer treatment. Cell migration and proliferation were evaluated using the modified Boyden chamber method and MTS assay, respectively. Although PD-98059 alone did not show any effect on AoSMCs, it completely blocked LacCerinduced AoSMC migration and proliferation at 10 M (P Ͼ 0.05; Fig. 6, C and D) . These findings suggest that LacCer induces AoSMC migration and proliferation through the ERK1/2 signaling pathway.
DISCUSSION
The present study details several new findings in terms of LacCer in the regulation of AoSMC functions. LacCer promotes AoSMC proliferation and migration and upregulated the expression of PDGFR-B, ␤ 3 -integrin, ␣ v -integrin, MMP1, and MMP2. It also increases superoxide generation and activates the ERK1/2 signal pathway in AoSMCs. These data demonstrate the VSMC migration is a key process in the pathogenesis of atherosclerosis and restenosis. For the first time, we report here that LacCer promotes AoSMC migration in a concentrationand time-dependant manner with the maximal effect at 10 M up to 192% compared with the negative control. The modified Boyden chamber assay is a well-recognized cell migration in vitro assay. Using a fluorescence blocking membrane allowed us analyze the cells that migrated to the lower chamber in situ. An image of the lower chamber directly showed the migrated AoSMCs. A wound healing assay was used to demonstrate the effect of LacCer on AoSMC migration and proliferation after 16 h of treatment. In addition, LacCer has additive effects with FCS on AoSMC migration. The specificity of LacCer-induced cell migration was confirmed by LacCer neutralizing antibody, which effectively blocked the LacCer effect.
Previous studies (5, 9) have indicated that LacCer could affect SMC proliferation at a range of 0 -10 M. However, the mechanisms are not known. The findings in the present study significantly extended our understanding on this important aspect. In fact, we have shown that LacCer increases AoSMC proliferation in a concentration-and time-dependent manner. Using 10 M LacCer, we repeatedly observed increased AoSMC proliferation over 155-175% compared with the negative control.
The underlying molecular mechanisms of LacCer-induced SMC dysfunction are large unknown. The present study explored the alteration of several key molecular events with LacCer treatment in AoSMCs. We found that LacCer upregulates the expression of several molecules related to cell migration and proliferation, including PDGFR-B, ␤ 3 -integrin, ␣ vintegrin, MMP1, and MMP2. Interestingly, LacCer had the greater responses at the protein level compared with mRNA changes. For example, the induction of ␣ v -integrin mRNA was only ϳ20%, whereas the protein was induced almost 3-fold. This suggests that LacCer may have important effects on protein expression at the posttranscriptional level. Cell migration and proliferation require the interaction of cell surface integrin receptors with the surrounding extracellular matrix (31) . Integrins are a family of heterodimeric transmembrane glycoproteins consisting of noncovalently associated ␣-and ␤-chains. The integrin complexes ␣ v ␤ 3 and ␣ v ␤ 5 have been shown to be expressed on VSMCs and to regulate their migration through interactions with the extracellular matrix (18). In the present study, we showed that the ␣ v ␤ 3 -integrin neutralizing antibody significantly blocked LacCer-induced AoSMC migration, indicating that ␣ v ␤ 3 -integrin may be functionally involved in LacCer-induced AoSMC migration. However, we did not investigate whether other molecules, including PDGDR-B, MMP1, and MMP2, have functional roles in LacCerinduced AoSMC migration. Previous reports (31, 33) have shown that MMPs and PFGDR-B are involved in VSMC migration.
ROS may serve as signaling molecules to activate protein kinases and transcription factors, resulting in alterations of specific gene expression and cellular functions (27, 28) . A previous study (5) has shown that LacCer could induce superoxide generation in VSMCs and could mediate cell proliferation via the activation of the kinase cascade. In the present study, we further demonstrated increased superoxide generation in AoSMCs in response to LacCer treatment. More importantly, we showed that both the antioxidants SeMet and MnTBAP effectively blocked the effect of LacCer on AoSMC migration and proliferation. Oxidative stress is a complex process that involves different ROS species, mitochondrial functions, and several enzymes. Different antioxidants may have different mechanisms to inhibit oxidative stress. SeMet is the major component of dietary selenium, of which the recommended daily allowance by the United States Food and Drug Administration is 50 g/day. The antioxidant effect of SeMet is mediated by a mechanism of intramolecular transsulfuration reaction to form selenocystein, which increases the activities of the internal antioxidant enzymes glutathione peroxidase and thioredoxin reductase (1) . In addition, SeMet is able to directly interact with some oxidant molecules or oxidant-generating ions (3, 29) . Previously, we (3) have demonstrated that SeMet can effectively block lysophosphatidylcholine-induced oxidative stress and endothelial dysfunction in porcine coronary arteries. However, we cannot confirm whether SeMet acts on the superoxide anion. Therefore, we used a second antioxidant, MnTBAP, which has SOD-like activity. Its blocking effects on LacCer-induced cell migration and proliferation can confirm the critical role of superoxide anion in SMC dysfunction. These findings indicate that ROS play an important role in the biological activities of LacCer in VSMCs.
MAPKs are involved in the regulation of development, cell activation, proliferation, and vascular contraction (15, 21) . They play an important role in the regulation of VSMC activation (8) . In the present study, we found that LacCer increases transient phosphorylation of ERK2, but not p38 and JNK, using a new Luminex technology of the Bio-Plex assay. Western blot analysis also confirmed that LacCer can induce the phosphorylation of EKR1/2. Both SeMet and MnTBAP effectively inhibited the LacCer-induced phosphorylation of ERK1/2. ERK1/2 phosphorylation has a functional significance because the specific ERK1/2 inhibitor PD-98059 can completely inhibit the promoting effect of LacCer on AoSMC migration and proliferation. These data are consistent with those of a previous study (4) showing that LacCer stimulated the activation of p44 MAPK and the expression of the transcription factor c-fos (4). Our study suggests that LacCerinduced cell migration and proliferation might mediate a common signal pathway as ERK1/2 activation in AoSMCs. At the present time, it is not known how LacCer initiates this signal event or whether LacCer binds to a receptor on the cell surface. It is suggested that LacCer added exogenously to the culture medium may be incorporated into the plasma membrane of the cell. The lipophilic ceramide moiety of LacCer could insert into the lipid bilayer and thus increases the proportion of this lipid by clustering within the cell membrane, which contributes cellular functions (19) .
Cultured AoSMCs may lack much of the normal phenotype of in vivo cells and may not respond in the same manner as freshly dispersed cells. It could be a limitation of the present study that our data were generated from cultured human AoSMCs. Future studies should include freshly dispersed human and animal VSMCs or intact vascular tissues as well as in vivo investigations. PDGF has been shown to cause phenotypic remodeling of SMCs, as reflected in decreased expression of smooth muscle-specific markers. It is not clear whether LacCer could cause similar changes. In the present study, the effects of antioxidants and ERK inhibitors on the expression of integrins and MMPs were not determined and are warranted in future investigations.
In summary, LacCer levels are clinically associated with vascular lesion formation. The present study explored the possible effects and molecular mechanisms of LacCer on AoSMCs. LacCer significantly promotes cell migration and proliferation in AoSMCs through increased oxidative stress, ERK1/2 activation, and the expression of several key molecules related to cell migration and proliferation. Antioxidants and the ERK1/2 inhibitor effectively blocked these effects of LacCer in AoSMCs. This study provides a better understanding of the roles of LacCer on the vascular system and suggests new therapeutic strategies to control CVD.
